Products containing free cannabis, appropriate pharmacovigilance asset to a better quality of everyday life through better safety and efficacy

---

Antonio Steardo

University of Salerno, Italy

: J Pharm Sci Emerg Drugs

Abstract

---

Following decades of research, the retrieval of components in Cannabis has made feasible the study of several psychotropic and non-psychotropic compounds that this herb and its variants contain. Useful new non-medical products have appeared on the market and this presentation aims to assess the pharmacological impact these on a wide population of consumers. Nowadays, a broad variety of cosmetics, food, supplements, and many other products attract wide-ranging consumption on the market. This presentation aims to discuss and introduce ideas on a better perspective on Pharmacovigilance to control properly the broad consumption of new-fashionable and new-taste products. Indeed, passed collected data can delineate a strategy for a correct prevision from collected knowledge. It would be Pharmacovigilance management. Improve the management of sometimes harmful side effects and represents a step forward in public health. The aim of this presentation is to convince that by an appropriate Pharmacovigilance asset and by new data analysis strategy, it is possible to obtain an innovative guide to correct use. Safety and efficacy would improve the general quality of life, as these products are readily available on the market, throughout all pharmacovigilance connected skills.

Biography

---

Antonio Steardo specialized in Pharmacology and graduated in Pharmacy and Pharmaceutical Chemistry. Now he has more than twenty years of experience in the pharmaceutical products sector since elementary school; his personal curiosity for chemistry manifested itself during games and continued with lectures at the department of science at the University of Salerno from the age of eight years old. Therefore, during the cycle of studies, he prefers biochemistry and biochemistry of drug action, graduating in July 2007 with a thesis on the functioning of the Endocannabinoid system in Alzheimer’s disease in Pharmacology. Following the beginning of his pharmaceutical chemistry studies, he stopped for a competition as a postgraduate in Pharmacology at the University of Rome La Sapienza in July 2014. Continuing his personal professional development and skills, he enrolled in continuing professional training at the University of Oxford to follow courses on Experimental and Translation Therapy and on Medical Research. His desire to improve leads him to attend international conferences and seminars to this day.